These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Control of the heparin induced bleeding risk in haemodialysis patients (author's transl)]. Vogel GE, Kopp KF. Med Klin; 1976 Jan 16; 71(3):116-9. PubMed ID: 1250190 [Abstract] [Full Text] [Related]
4. [Standardisation and quality control of the thromboplastin time (Quick test) (author's transl)]. Beck EA. Ther Umsch; 1977 May 16; 34(5):347-9. PubMed ID: 867316 [No Abstract] [Full Text] [Related]
7. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats. Greene CE, Meriwether E. Am J Vet Res; 1982 Aug 16; 43(8):1473-7. PubMed ID: 7103231 [Abstract] [Full Text] [Related]
9. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays. Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R. Thromb Haemost; 2008 Feb 16; 99(2):427-34. PubMed ID: 18278195 [Abstract] [Full Text] [Related]
10. Anticoagulation monitoring. Ng VL. Clin Lab Med; 2009 Jun 16; 29(2):283-304. PubMed ID: 19665679 [Abstract] [Full Text] [Related]
11. [Laboratory control of anticoagulant treatments (author's transl)]. Samama M, Conard J, Horellou MH. J Mal Vasc; 1981 Jun 16; 6(4):257-61. PubMed ID: 7320641 [Abstract] [Full Text] [Related]
17. [Coagulation studies and treatment with heparin in a case of hemolytic-uremic-syndrome (author's transl)]. Ploier R. Padiatr Padol; 1974 Jun 16; 9(3):276-81. PubMed ID: 4408956 [No Abstract] [Full Text] [Related]